Recombinant factor VIIa and the trauma patient.
Criddle
Laura M
LM
Oregon Health & Science University, Portland, OR, USA. criddlel@ohsu.edu
D004334:Drug Administration Schedule; D016527:Drug Costs; D004348:Drug Labeling; D016903:Drug Monitoring; D016529:Emergency Nursing; D004638:Emergency Treatment / Q000379:methods*; D005167:Factor VII / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D015942:Factor VIIa; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000451:nursing; D006489:Hemostatic Techniques; D006801:Humans; D024802:Nurse's Role; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D012449:Safety; D013997:Time Factors; D016896:Treatment Outcome; D014947:Wounds and Injuries / Q000150:complications*
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa